According to a new report by Reports and Data, the global Anesthesia CO2 Absorbent Market is expected to reach USD 135.57 million by 2030, with a revenue compound annual growth rate (CAGR) of 9.1% during the forecast period. The rise in the number of surgical procedures performed for the treatment of various medical conditions such as neurological conditions, cardiac arrest, respiratory ailments, and diabetes has resulted in an increase in demand for anesthesia, which is expected to drive the market revenue growth over the forecast period.

The National Center for Biotechnology Information (NCBI) published data in 2020 that around 310 million major surgeries are performed globally each year, with around 40 to 50 million in the U.S, and 20 million in Europe.

Get a free sample PDF of the report, visit @

https://www.reportsanddata.com/download-free-sample/1365

The market growth is also driven by the higher frequency of surgical treatments for cardiothoracic, orthopedic, vascular, and neurological diseases or disorders, as well as increasing prevalence of cardiovascular disease, arthritis, and cancer. The manufacturers are introducing new medical technologies to meet unmet patient demands. The launch of new and advanced products is expected to play a major role in the revenue growth of the global anesthesia CO2 absorbent market.

The market is segmented based on product, type, form, end-user, and region. Based on product, the market is segmented into soda lime, medisorb, dragersorb, amsorb, litholyme, and other products. The soda lime segment is expected to register a steady revenue CAGR of 2.1% over the forecast period, mainly due to supportive initiatives taken by governments of various countries and research development initiatives to develop better CO2 absorbent formulations.

To know more about the report, visit @

https://www.reportsanddata.com/inquiry-before-buying/1365

Based on type, the market is segmented into traditional and premium, with the premium segment expected to register a robust revenue growth rate over the forecast period. Based on form, the market is segmented into granular form and powdered form, with the powdered form segment expected to register a faster revenue growth rate over the forecast period due to the increasing demand for powdered anesthesia CO2 absorbent than the granular form.

Based on end-user, the market is segmented into hospitals, clinics, and other end-users, with the hospitals segment accounting for the largest revenue share in 2021 and expected to register a significantly faster growth rate during the forecast period.

The Asia-Pacific anesthesia CO2 absorbent market is expected to register the fastest growth rate over the forecast period, due to the increase in the geriatric population, which is likely to result in a significant increase in demand for surgeries in Asia-Pacific. The key players profiled in the market report include Drägerwerk AG Co. KGaA (Germany), GE Healthcare (U.S.), Allied Healthcare Products, Inc. (U.S.), Smiths Medical, Inc. (U.S.), Vyaire Medical, Inc. (U.S.), Intersurgical, Ltd. (England), Armstrong Medical, Ltd. (U.K.), Molecular Products Group, Ltd. (England), Micropore, Inc. (U.S.), Lowenstein Medical UK, Ltd. (England), and Atrasorb (Brazil).

In conclusion, the global anesthesia CO2 absorbent market is expected to witness significant growth over the forecast period, driven by the increase in the number of surgical procedures performed and the higher frequency of surgical treatments for various diseases or disorders. The market is expected to grow in different segments such as product, type, form, end-user, and region, and the Asia-Pacific region is expected to register the fastest growth rate. The manufacturers are also introducing new medical technologies to meet unmet patient demands, which is expected to play a significant role in the revenue growth of the market.

Request a customized copy of the report @

https://www.reportsanddata.com/request-customization-form/1365

Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.  

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact:

John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

Browse for more reports…